Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
However, whether genetic variation in IL-17 is associated with altered susceptibility to tuberculosis is unknown.
|
23219503 |
2013 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Overall, our findings demonstrated that the AA genotype from the IL-17A rs2275913 SNP is positively associated with protection to active tuberculosis but related to higher disease severity in the Argentinean population.
|
28098168 |
2017 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
There was no significant association of IL-17A rs22275913 polymorphism with susceptibility to TB in Asians or Caucasians.
|
26899623 |
2016 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the TT genotype of IL-17A rs3748067 might be a risk factor for TB in Asians; the A allele, as well as the AG and AA+AG genotypes of the rs2275913 polymorphism, might be protective against TB in Caucasians.
|
29297452 |
2017 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In contrast, SNPs in the proinflammatory IL17A and IL17F genes (rs2275913 and rs763780, respectively), found previously to correlate with the disease occurrence in Chinese population, were not significantly associated with tuberculosis in the Croatian population.
|
25857634 |
2015 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To date, only one study performed in Chinese Han population has found an association between IL-17F sequence variants and susceptibility to tuberculosis, but no relationship has been found with another single nucleotide polymorphism (SNP) in IL-17A gene (rs2275913).
|
23778030 |
2013 |
Tuberculosis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that genetic polymorphisms of IL-17 and TLR4 may play a role in host susceptibility to tuberculosis in the Chinese Han population.
|
27339100 |
2016 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
It is concluded that 4-1BB has the potential to be used as a biomarker to identify MAIT cells with enhanced IFN-γ and IL-17 responses that might be associated with tuberculosis infection control.
|
29631725 |
2018 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Since increased IL-17A levels are observed to be localized in the lung compartments (BAL and lymphocytes) in comparison to circulating levels, an inhalable PI3Kδ inhibitor, which is currently utilized for inflammatory airway diseases characterized by IL-17A over-secretion, may be a therapeutic option for active TB disease.
|
31736982 |
2019 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, IL-17 and SLAM have opposing effects on IFN-gamma production through CREB activation in persons with tuberculosis.
|
19199539 |
2009 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
IL17A augments autophagy in Mycobacterium tuberculosis-infected monocytes from patients with active tuberculosis in association with the severity of the disease.
|
28581888 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
There is evidence that IL-17 plays a role in the defense against tuberculosis.
|
28916742 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
These findings strongly support the development of a NE-TB vaccine as a novel, safe and effective, first-of-kind IL-17 inducing mucosal vaccine for potential use in humans.
|
28774560 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mice immunized with BCG expressing low levels of LTAK63 (rBCG-LTAK63<sub>lo</sub>) showed higher Th1 cytokines and IL-17 in the lungs, and when challenged intratracheally with Mycobacterium tuberculosis displayed a 2.0-3.0 log reduction in CFU as compared to wild type BCG.
|
28522873 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our objective was to analyze, in an in vitro model, the influence of Infliximab on the granulomatous reactions and on the production of antigen-specific cytokines (TNF-α, IFN-γ, IL-12p40, IL-10 and IL-17) from beads sensitized with soluble Bacillus Calmette-Guérin (BCG) antigens cultured in the presence of peripheral blood mononuclear cells (PBMC) from TB patients.
|
29543912 |
2018 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, IL-17 production by neutrophils contributed to collagen-induced arthritis development during MTB infection.
|
28821374 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present findings deepen our understanding of the role of IL-17 in MDR-TB and highlight the influence of the genetic background of the infecting M. tuberculosis strain on the ex-vivo Th17 response.
|
27681197 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Moreover, the aptamer-treated H37Rv can stimulate IFN-γ, IL-15 and IL-17 secretion of macrophages compared with H37Rv (no treated).
|
21643749 |
2012 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our studies highlight the potential value of targeting the IL-17-CXCL13 pathway rather than the IFNγ pathway as a new strategy to improve mucosal vaccines against TB.
|
23299616 |
2013 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results show that TB(+)HIV(+) pleurisy results in significantly reduced frequency of CD4(+)IL-17(+)RORC(+)STAT3(+) Th17 cells compared to TB(-)HIV(-)ex vivo (p = 0.0054) and was confirmed in conditioned media studies in vitro (p = 0.0001).
|
27450010 |
2016 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We further directly linked IL-17A as the responsible contributor of improved immunity against M.tb infection.
|
30778118 |
2019 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Metabolites from anaerobic bacterial fermentation may, therefore, increase TB susceptibility by suppressing IFN-γ and IL-17A production during the cellular immune response to M. tuberculosis.
|
28366509 |
2017 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Accordingly, we examined the impact of individual versus combined neutralization of TNF-α and IL-17A in a mouse model of rheumatoid arthritis (collagen-induced arthritis) and the concomitant susceptibility to infections that are likely to manifest as side effects of blocking these cytokines (oral candidiasis or tuberculosis).
|
30745461 |
2019 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Impairment in TNF, IL-1β, and IL-17 production upon stimulation with mycobacterial antigens may contribute to the increased susceptibility to M. tuberculosis infection observed in HTLV-1 infected individuals.
|
29523325 |
2018 |
Tuberculosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The expression of IL-17 and IL-10 was significantly increased in active TB patients in comparison to that in latent TB or control groups (IL-17: 16.85±9.68 vs. 7.23±5.19 or 8.21±5.51pg/mL, p<0.05; IL-10: 28.70±11.27 vs. 20.25±8.57 or 13.94±9.00pg/mL, p<0.05).
|
27932286 |
2017 |